Introduction
============

*Shigella,* a member of the Enterobacteriaceae family, is considered as a health problem across the world. Shigellosis is a self-limiting infectious disease in humans that is caused by *Shigella*, however, morbidity and mortality rates are highest among young children, elderly and immunocompromised patients. Upon antibiotic therapy, duration of symptoms and the transmission rate is reduced by shortening the period of *Shigella* excretion. However, life-threatening complications can occur in severe cases with Multi-Drug Resistant (MDR) *Shigella,* which defines the ability of organisms to withstand the inhibitory effect of at least one agent in ≥3 antimicrobial categories ([@B1])([@B2])([@B3]).

Over the past few decades, research in Iran ([@B2]), Malaysia ([@B4]), and West Nepal ([@B5]) revealed that *Shigella* is resistant to used traditional antimicrobials, similar to other bacteria. The rapid emergence of antimicrobial resistance is the public health is a concern that must be controlled ([@B6]).

The main mechanisms of Antimicrobial Resistance (AMR) are target site changes, production of an enzyme, reduced drug accumulation by the efflux pump or diminishing the permeability that can be inherent or adventitious. Control of antibiotic resistance is achieved by acquisition and dissemination of genes, through mobile genetic elements or mutations ([@B7]).

Tetracyclines, which were discovered in the 1940s, are broad-spectrum antibiotics for human, animals and plants. The first tetracycline-resistant bacteria, *Shigella*, was isolated in 1953, however, nowadays the majority of *Shigella spp*. have become resistant to it ([@B8])([@B9]).

The key mechanism of resistance to tetracycline arises due to the efflux pump and ribosomal protection system, which are under the control of structural and regulatory genes. Efflux pump genes code membrane proteins which export tetracycline from the cell that render it ineffective. Twenty-nine different tetracycline resistance (tet) genes were identified in gram positive and gram negative bacteria; eighteen of the *Tet*genes encode efflux pump, and it has been identified that *tetA, tetB, tetC, tetD, tet E, tetG, tetH, tetI, tetJ, tetY, tet*([@B30]) and *tet*(31) are found in gram negative bacteria. Some of studies discovered *tet* A, *tet*B, *tetC*and *tetD*genes in *Shigella*, while the Antibiotic Resistance Genes Database (ARDB) does not report *tetC* for *Shigella*([@B8])([@B9])([@B10]).

Efflux pumps belong to the six different groups, coding tetracycline resistance, which extrude tetracycline-cation complexes out of the bacteria for protons. Group 1 including *tetA*, *tetB* *tetC* and *tetD,* are frequently found in *Shigella* ([@B10]).

This study aimed to investigate *tetA*, *tetB*, *tetC* and *tetD* genes and the effect of efflux pump inhibitors on *Shigella* tetracycline resistant isolates.

Materials and Methods
=====================

**Isolates**

This study was conducted on 50 *Shigella*isolates collected from children diarrheic stools in Tehran, Iran (from November 2012 to October 2013). All of the isolates were identified and confirmed using conventional biochemical tests, during year 2015 ([@B11]) .

Serogrouping of *Shigella* isolates was done by slide agglutination assay using A, B, C and D antisera (Baharafshan Institute of Research & Development, Tehran, Iran). Polymerase Chain Reaction (PCR) assay targeting the *ipaH*(for genus *Shigella*)*, rfc*(for species*Shigella flexneri*), and*wbgZ*(for species *Shigella sonnei*) genes was performed, [Table 1](#T1){ref-type="table"} ([@B12]) ([@B13]).

**Antimicrobial Susceptibility Testing**

The susceptibility of isolates was examined using the disk diffusion method, in accordance with Clinical and Laboratory Standards Institute (CLSI 2015 ) guidelines ([@B14]). The antibiotic susceptibility of*Shigella* isolates was examined against the following antibiotics (MAST Company, Merseyside, and U.K): minocycline (30 µg), tetracycline (30 µg), doxycycline (30 µg), ampicillin (10 µg), streptomycin (10 µg), trimethoprim-sulfamethoxazole (25 µg), nalidixic acid (30 µg), norfloxacin (10 µg), ciprofloxacin (5 µg) and levofloxacin (5 µg) on Muller --Hinton agar. This study was conducted for all of isolates in duplicates and *Escherichia coli* ATCC 25922 was used as a quality control strain in susceptibility testing.

###### 

Primers Used in This Study

  ----------------------------------------------------------------------------------------------------------
  Primer      Primer sequence (5^'^to 3^'^)   Annealing temperature ^0C^   Product size in\   Presence of\
                                                                           bp                 Genes%
  ----------- ------------------------------- ---------------------------- ------------------ --------------
  *ipaH*(F)   GTTCCTTGACCGCCTTTCCGATACCGTC    60                           619                100

  *ipaH*(R)   GCCGGTCAGCCACCCTCTGAGAGTAC                                                      

  *wbgZ*(F)   TCT GAATATGCCCTCTACGCT          60                           430                86

  *wbgZ*(R)   GACAGAGCCCGAAGAACCG                                                             

  *rfc*(F)    TTTATGGCTTCTTTGTCGG             60                           537                14

  *rfc*(R)    CTGCGTGATCCGACCATG                                                              

  *tetA*(F)   GCTGCAAGCAATGTTGTCCA            59                           190                66

  *tetA*(R)   CAGGCAGAGCAAGTAGAGGG                                                            

  *tetB*(F)   CGCTAACCACTTTGGCGTAT            59                           211                12

  *tetB*(R)   AGCTCCTGTGATCCCTGAAA                                                            

  *tetC*(F)   CTTGAGAGCCTTCAACCCAG            55                           418                0

  *tetC*(R)   ATGGTCGTCATCTACCTGCC                                                            

  *tetD*(F)   TGGGCAGATGGTCAGATAAG            53                           787                0

  *tetD*(R)   CAGCACACCCTGTAGTTTTC                                                            

  *rpsL*(F)   TACATCGGTGGTGAAGGTCA            59                           154                100

  *rpsL*(R)   ACTTGGAACGAGCCTGCTTA                                                            
  ----------------------------------------------------------------------------------------------------------

**Determination of Minimal Inhibitory Concentration (MIC) with and without efflux pump inhibitor**

Tetracycline resistant isolates in Disk diffusion method were used for Minimum Inhibitory Concentration (MIC) determination.

Determination of MIC for tetracycline was achieved by micro broth dilution procedure in the range of 0.5 to 1024 µg/mL with and without efflux pump inhibitor. Carbonyl cyanide m-chlorophenylhydrazone (CCCP) was used as an efflux pump inhibitor at final concentration of 50 µg/mL ([@B15])([@B16]).

Then, effect of CCCP on growth of *Shigella* isolates and*Escherichia coli* (as a control) was examined ([@B15]). The isolates with tetracycline MIC of ≤4 µg/mL and ≥ 16 µg/mL were considered as susceptible and resistant, respectively, according to CLSI guidelines.

**DNA Extraction**

All of *Shigella* isolates were grown at 37 °C in Luria-Bertani (LB) broth media. Subsequently, 2 mL of overnight cultures were centrifuged and DNA extracted from the sediment sample using a DNA extraction kit (Exgene Cell SV kit Gene All Biotechnology Co. Ltd Korea).

Purified genomic DNA was stored in sterile DNase free tubes for PCR screening.

**Oligonucleotides used in Polymerase Chain Reaction**

Polymerase Chain Reaction amplification of *ipaH*, *wbgZ*,*rfc*, *tet*C and *tetD* genes was performed with primers used in previous studies ([@B12])([@B13])([@B17]). Other primers (*tetA* and *tetB*) were selected based on the sequences available on GenBank for each gene and then Primer3Plus-Bioinformatics was used to generate the candidate primer pairs. All of primers used in this study were synthesized by the TAGC Company (Tag Copenhagen A/S Kong Georgs Vej 12 DK-2000 Frederiksberg Denmark); primer sequences are listed in [Table 1](#T1){ref-type="table"}. Stock suspension (100 Pmol) was made in molecular grade water and stored at -70°C; all of primers were diluted to 10 Pmol before use.

**Conventional Polymerase Chain Reaction**

Originally, PCR was performed to detect the *ipaH* gene for confirming isolates as genus of *Shigella,* and then presence of *wbgZ*,*rfc,* *tetA*, *tetB* , *tetC* and *tetD* genes was assessed. The PCR conditions were as follows: initial denaturation step at 94°C for 5 minutes, followed by 30 cycles consisting of denaturation (at 94°C for 1 minute), annealing (1 minute, separately adjusted for each set of primer pair, according [Table1](#T1){ref-type="table"}), and extension (at 72 °C for 1 minute), followed by a final extension step at 72 °C for 5 minutes. *Shigellaflexneri* ATCC 9290 and *S. sonnei* ATCC 1202 were used as controls in each assay.

Finally, an agarose gel was used to assess the PCR results.

**RNA Extraction and cDNA Synthesis**

All of isolates were cultured in LB agar media at 37 °C. ^.^One colony from each isolate was suspended in 1 mL of LB broth media and incubated at 37 °C for 18 to 24 hours.

Next, concentration of bacterial suspension was adjusted to 10^7^cfu /mL by OD in 625nm, and

400 microliter of bacterial suspension was centrifuged (3000 rpm/10 minutes). After centrifugation the supernatant was removed, the bottom sediment was resuspended in sterile normal saline, followed by another centrifugation. Subsequent to two washes, lysis buffer (340 µL)~,~ SDS (30 µL), carrier RNA (10 µL~)~and proteinase K (20 µL) were added to bacterial cell tubes. RNA was extracted by a kit and automated Mag Core Nucleic Acid Extractor.

Immediately after, 2 µL of RNA extracts was treated with mixture of DNase (2 µL) and buffer (2 µL) at 37°C/ 30 minutes. Subsequently, EDTA (2 µL) was added and incubated at 65°C ^/^10 minutes.

Purified genomic RNA that was collected in sterile DNase free tubes was used to synthesize PCR cDNA.

In order to control quality of RNA extraction, 5 µL treated RNA and 5 µL untreated were used for agarose gel electrophoresis. Also, concentration and purity of RNA were assessed by measuring the ratio of UV absorbance at 260 nm and 280 nm, using a Nano Drop 2000C spectrophotometer.

Extracted RNA was used to synthesize cDNA by Revert Aid First Strand cDNA Synthesis kit (Thermo, Dreieich) and Step One plus (ABI). Also, concentration and purity of cDNA was assessed, and the cDNA was stored in sterile DNase free tubes at -20°C.

**Evaluation of gene expression by real time Polymerase Chain Reaction**

Gene expression analysis was performed by Evergreen kit (Maxima® SYBR Green/Fluorescein qPCR Master Mix) in Step One plus (ABI) and ECO (Illumina USA) instruments, using *tetA* and *tetB* specific primers for efflux pump. The *rpsL* gene was chosen as a reference primer housekeeping gene ([Table 1](#T1){ref-type="table"}). Normalization of cDNA and primers concentration was done for each reaction, the volume of cDNA for each isolate was adjusted to 20 ng per reaction. The real time PCR conditions of initial denaturation of 10 minutes at 95^◦^C, 40 cycles of 15 seconds at 95^◦^C for denaturation, 45 seconds annealing and 1-minute at 72^◦^C for extension, and at 72^◦^C for 5 minutes, followed by a melting curve analysis. Calculation of gene expression was done using comparative quantification of 2^(∆∆Ct)^-based on Pfaffl method ([@B18]). Amplification efficiency was determined from analysis of a serial dilution of a control strain cDNA (at certain concentrations). Analysis of data was performed with Step One Software v2.3, and qPCR products were used for electrophoresis on agarose gel for controlling the results. Mean values of duplicated runs of each isolate in real time PCR was used for analysis.

Results
=======

**Isolates**

A total of 50 *Shigella*spp*.*were isolated during the period of the study between November 2012 and October 2013. The isolates of *Shigella* were identified by conventional biochemical tests and sero-grouping method. Among the 50 *Shigella* isolates confirmed by PCR, 16% (n=8) was identified as *Shigella flexneri*(*S. flexneri*) and 84% (n=42) as *Shigella sonnei*(*S. sonnei*). Species-specific PCR analyses of *ipaH* gene confirmed the identity of all isolates as *Shigella* spp. Moreover, amplification of the genes *wbgZ* and *rfc* confirmed serogrouping results ([Table1](#T1){ref-type="table"}).

**Antimicrobial susceptibility testing**

The results of antimicrobial susceptibility of *Shigella*spp*.* demonstrated that all of the isolates were MDR and resistant to three or more classes of antibiotics.

According to the results of antimicrobial susceptibility testing listed in [Table 2](#T2){ref-type="table"}, 96% of all isolates were resistant to tetracycline, 94% to doxycycline, and 2% to minocycline

###### 

Results of Antimicrobial Susceptibility

  Antibiotics                     Percentage of isolates   
  ------------------------------- ------------------------ -----
  Ampicillin                      76                       24
  Ciprofloxacin                   98                       2
  Doxycycline                     6                        94
  Levofloxacin                    100                      0
  Minocycline                     98                       2
  Nalidixic Acid                  82                       18
  Norfloxacin                     100                      0
  Streptomycin                    0                        100
  Tetracycline                    2                        96
  Trimethoprim-sulfamethoxazole   2                        98

###### 

Results of Minimum Inhibitory Concentration With and Without Efflux Pump Inhibitor

  -------------------------------------------------------------------------------------
  Range of MIC   512     256      128     64    32   16    8    4       2    1    0.5
  -------------- ------- -------- ------- ----- ---- ----- ---- ------- ---- ---- -----
  Without CCCP   2%\     78%\     16%\    0%    0%   0%    0%   4%\     0%   0%   0%
                 (n=1)   (n=39)   (n=8)                         (n=2)             

  With CCCP      0%      6%       40%     20%   6%   12%   0%   4%      0%   2%   10%

  No change      0%      4%       2%      0%    0%   0%    0%   4%      0%   0%   0%
  -------------------------------------------------------------------------------------

CCCP: Inhibitor n: Number of isolates

**Minimum Inhibitory Concentration Test**

All tetracycline resistant isolates were subjected to MIC determination with or without efflux pump inhibitor (CCCP). All of the isolates showed resistance by the MIC method ([Table 3](#T3){ref-type="table"}).

**Extraction of nucleic acid**

Majority of extracted nucleic acids (RNA, cDNA) indicated the acceptable ratio of UV absorbance at 260 nm and 280 nm for assessing the purity of DNA (about 2) and electrophoresis. A few extractions of RNA with poor results of electrophoresis were repeated.

**Conventional PCR**

The *IpaH* gene amplified with PCR, visualized a 619-bp band on agarose gel for all isolates and confirmed them as the genus of *Shigella*. In addition, amplification of *wbgZ* and *rfc*genes revealed 430 bp and 537 bp bands, confirming *Shigella* isolates as *S. sonnei* and *S. flexneri*, respectively.

Polymerase Chain Reaction amplification of *Shigella*isolates showed that 66% of isolates were positive for *tetA,* while only 12% of them were positive for *tetB.*Neither of the isolates was positive for *tetC* and *tetD*([Table 1](#T1){ref-type="table"})*.*

**Real Time Polymerase Chain Reaction**

As [Table 4](#T4){ref-type="table"} shows, PCR analysis of isolates demonstrated 78% against 12% for presence of *tetA* and *tetB* ([Table 4](#T4){ref-type="table"}).

Expression of*tetB*gene was seen in *S. flexneri* isolates, which were resistant to tetracycline.

*Shigella* *sonnei*isolates did not express *tetA*, and their MIC did not change after using CCCP (Table 4).

###### 

Results of Expression of *tet*A *and tet*B Genes by Real Time Polymerase Chain Reaction

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Isolates   Serogroup                          Resistance to Tetracycline         MIC\           MIC\        [1](#TFN1){ref-type="table-fn"} *tetA*   Expression of *tetA*\   [2](#TFN2){ref-type="table-fn"} *tetB*   Expression of *tetB* (fold)        Pattern of resistance
                                                                                   Without CCCP   With CCCP                                            (fold)                                                                                              
  ---------- ---------------------------------- ---------------------------------- -------------- ----------- ---------------------------------------- ----------------------- ---------------------------------------- ---------------------------------- -----------------------
  1          [4](#TFN4){ref-type="table-fn"}D   [6](#TFN6){ref-type="table-fn"}R   512            256         [8](#TFN8){ref-type="table-fn"}P         8.9                     N                                        [3](#TFN3){ref-type="table-fn"}0   T,D,SXT,S

  2          D                                  R                                  256            128         P                                        4.18                    N                                        0                                  T,D,SXT,S,AM

  3          D                                  R                                  256            128         P                                        7.3                     N                                        0                                  T,D,SXT,S,AM

  4          D                                  R                                  256            128         P                                        7.97                    N                                        0                                  T,D,SXT,S,AM

  5          D                                  R                                  256            128         P                                        1.13                    N                                        0                                  T,D,SXT,S,NA

  6          D                                  R                                  256            128         P                                        5.4                     N                                        0                                  T,D,SXT,S

  7          D                                  R                                  256            128         P                                        7.3                     N                                        0                                  T,D,SXT,S

  8          D                                  R                                  256            128         P                                        3.11                    N                                        0                                  T,D,SXT,S

  9          D                                  R                                  256            128         [9](#TFN9){ref-type="table-fn"}N         0.61                    N                                        0                                  T,D,SXT,S

  10         D                                  R                                  256            128         N                                        0.53                    N                                        0                                  T,D,SXT,S

  11         D                                  R                                  256            128         P                                        2.98                    N                                        0                                  T,D,SXT,S

  12         D                                  R                                  256            128         P                                        4                       N                                        0                                  T,D,SXT,S

  13         D                                  R                                  256            128         P                                        1.98                    N                                        0                                  T,D,SXT,S

  14         D                                  R                                  256            128         P                                        9.1                     N                                        0                                  T,D,SXT,S

  15         D                                  R                                  256            128         P                                        3.6                     N                                        0                                  T,D,SXT,S

  16         D                                  R                                  256            128         P                                        0.97                    N                                        0                                  T,D,SXT,S

  17         D                                  R                                  256            128         P                                        1.9                     N                                        0                                  T,D,SXT,S

  18         D                                  R                                  256            128         P                                        0.97                    N                                        0                                  T,D,SXT,S

  19         D                                  R                                  256            128         N                                        0.81                    N                                        0                                  T,D,SXT,S

  20         D                                  R                                  256            128         N                                        0.61                    N                                        0                                  T,D,SXT,S

  21         D                                  R                                  256            64          P                                        8,9                     N                                        0                                  T,D,SXT,S,AM

  22         D                                  R                                  256            64          P                                        2.8                     N                                        0                                  T,D,SXT,S,AM

  23         D                                  R                                  256            64          N                                        0.29                    N                                        0                                  T,D,SXT,S,NA

  24         D                                  R                                  256            64          P                                        1.01                    N                                        0                                  T,D,SXT,S

  25         D                                  R                                  256            64          P                                        4.5                     N                                        0                                  T,D,SXT,S

  26         D                                  R                                  256            64          N                                        0.76                    N                                        0                                  T,D,SXT,S

  27         D                                  R                                  256            64          P                                        6.53                    N                                        0                                  T,D,SXT,S

  28         D                                  R                                  256            64          P                                        4.7                     N                                        0                                  T,D,SXT,S

  29         D                                  R                                  256            64          N                                        0.67                    N                                        0                                  T,D,SXT,S

  30         D                                  R                                  256            64          N                                        0.34                    N                                        0                                  T,D,SXT,S

  31         D                                  R                                  256            32          N                                        0.31                    N                                        0                                  T,D,SXT,S,AM

  32         D                                  R                                  256            32          P                                        11.9                    N                                        0                                  T,D,SXT,S,NA

  33         D                                  R                                  128            32          P                                        11.8                    N                                        0                                  T,D,SXT,S,NA

  34         D                                  R                                  256            16          P                                        3.2                     N                                        0                                  T,D,SXT,S,NA

  35         D                                  R                                  256            16          P                                        5.8                     N                                        0                                  T,D,SXT,S,NA

  36         D                                  R                                  256            16          N                                        0.78                    N                                        0                                  T,D,SXT,S,NA

  37         D                                  R                                  256            16          P                                        8.6                     N                                        0                                  T,D,SXT,S

  38         D                                  R                                  256            16          P                                        4.8                     N                                        0                                  T,D,SXT,S

  39         D                                  R                                  256            16          P                                        6.3                     N                                        0                                  T,D,SXT,S

  40         D                                  R                                  256            256         P                                        0                       N                                        0                                  T,D,SXT,S

  41         D                                  R                                  256            256         P                                        0                       N                                        0                                  T,D,SXT,S

  42         D                                  R                                  128            128         N                                        0                       N                                        0                                  T,D,SXT,S

  43         [5](#TFN5){ref-type="table-fn"}B   R                                  128            1           N                                        0                       P                                        5.69                               T,MIN,SXT,S,AM

  44         B                                  R                                  128            0.5         N                                        0                       P                                        3.56                               T,D,SXT,S,AM

  45         B                                  R                                  128            0.5         N                                        0                       P                                        2.44                               T,D,SXT,S,AM

  46         B                                  R                                  128            0.5         N                                        0                       P                                        0.88                               T,D,S,AM

  47         B                                  R                                  128            0.5         N                                        0                       P                                        2.51                               T,D,SXT,S

  48         B                                  R                                  128            0.5         N                                        0                       P                                        0.36                               T,SXT,S

  49         B                                  ^7^S                               4              4           P                                        0                       N                                        0                                  SXT,S,NA

  50         B                                  S                                  4              4           P                                        0                       N                                        0                                  SXT,S,AM,NA,CIP
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

MIC**≤**4 μg/mL indicates susceptibility to tetracycline. T=Tetracycline D= Doxycycline MIN=Minocycline S=Streptomycin SXT= trimethoprim-sulfamethoxazole AM=Ampicillin NA=Nalidixic Acid CIP=Ciprofloxacin

Presence of tetA by conventional PCR

Presence of tetA by conventional PCR

0: No expression

D= *S. sonnei*

*B=S. flexneri*

R: Resistance

S: Sensitive

P; Positive

N: Negative MIC ≥ 16 μg/ml indicate resistance to tetracycline.

Discussion
==========

In concordance with the results of other studies in Iran, *S. sonnei* was the dominant species in this study ([@B19])([@B20])([@B21])([@B22]). Increasing prevalence of *S. sonnei* in other regions like the United States may be related to increasing environmental adaptation of *S.* *sonnei*([@B23])([@B24]). All of the*S. sonnei* and 75% of *S. flexneri* were MDR that could lead to an emergency in treatment of shigellosis, especially because of increased resistance to first -line antimicrobial agents ([Table 2](#T2){ref-type="table"}).

Tetracycline was discovered in 1940, most of bacteria were susceptible to this drug in mid-1950. Resistance to tetracycline was first reported in year 1957, also tetracycline-resistant *S.sonnei*cases (35%) were reported in 1978 ([@B25]). Nowadays, most *Shigella*spp., such as that of the current study (96%), are resistant to tetracycline. Hence, tetracycline cannot be a suitable choice for treatment of shigellosis.

Moreover, *Shigella* isolates that were susceptible to tetracycline were also sensitive to doxycycline and minocycline. A description for difference in the rate of resistance between minocycline, doxycycline and tetracycline can refer to less use of minocycline ([Table 2](#T2){ref-type="table"}).

The MIC results for tetracycline showed high resistance (MIC ≥ 256 µg/mL) in most of *shigella* isolates ([Table 3](#T3){ref-type="table"}). One research in Hong Kong from 1986 to 1995 demonstrated MIC of ≥ 256 µg/mL for *S.sonnei*and *S.flexneri* ([@B26]) . It seems that resistance to tetracycline can be related to efflux pump, ribosomal protection system or other mechanisms ([@B9]). It is considerable that all tetracycline resistant *Shigella* isolates were also resistant to trimethoprim-sulfamethoxazole and streptomycin ([Table 4](#T4){ref-type="table"}). High rates of resistance to trimethoprim-sulfamethoxazole and tetracycline among *Shigella* isolates were reported in Iran and other countries ([@B2])([@B27]). Barman examined the relationship between simultaneous resistance to trimethoprim sulfamethoxazole and streptomycin with a 6.3-kb plasmid and observed that the isolates were resistant to tetracycline as well ([@B28]). This phenomenon leads us to another factor that can be the cause of one or more antimicrobial resistance in bacteria.

It has been observed that in the presence of CCCP, as the inhibitor of efflux pump, MIC value is decreased. Moreover, CCCP can change some resistant isolates to sensitive ones, and it can be concluded that inhibiting of efflux pump decreases MIC ([Table 3](#T3){ref-type="table"}). However, MIC of 10% of resistant isolates did not change in the presence CCCP. Also, MIC of most isolates was reduced, yet they remained resistant. Thus, the other factors (except efflux pump) might lead to resistance in isolates ([Table 3](#T3){ref-type="table"}).

It seems that resistance to tetracycline can be associated with efflux pump, ribosomal protection system or other mechanisms ([@B9]).

In order to evaluate efflux-mediated tetracycline resistance, the presence of tetA, *tetB*, *tetC* and *tetD* genes in DNA of *Shigella* isolates were investigated by PCR ([@B10]). Neither of the isolates showed amplification of *tetC* and *tetD*, however, they were positive for 66% of *tetA* and 12% of *tetB*([Table 4](#T4){ref-type="table"}). The study of Martinez et al. (1986) demonstrated the presence of *tetC* in *S. flexneri* (12.5%) and*S. sonnei* (72.5%) while *tetD* was observed only in *S. sonnei* (8%). The study of Hartman et al. (2003) revealed that 3.1% of *S. sonnei* harbored *tetC*, yet this was negative for *S. flexneri*([@B29]). Also,*TetD* was observed in *S. sonnei*and *S. dysenteriae*serotype 1 ([@B30]). Inconsistency between the results of our study (n=50) and that of Hartman (n=369) and Martinez (n=33) can be related to different number of isolates ([@B30])([@B29]). All of our isolates with *tetB* were defined as *S. flexneri*and isolates positive for *tetA* defined as *S. sonnei* and *S. flexneri* ([Table 4](#T4){ref-type="table"})*.*Results of the study of Mandomando et al. revealed that 15% of *Shigella*isolates were positive for *tetA* and 79% for *tetB* ([@B1]). The difference between the study of Mandomando and the present research may be related to low ratio of *S. sonnei*(n=15) against *S. flexneri*(n=94), as *tetA* was seen in *S. sonnei*more than*S. flexneri*([@B1])*.* It is important to note that two susceptible isolates to tetracycline were positive for *tetA* yet negative for *tetB*. This result shows that the presence of *tetA* cannot explain resistance to tetracycline in *S. flexneri.* Most of the resistant isolates to tetracycline were positive for *tetA* and negative for *tetB*. In the presence of CCCP, the value of MIC for tetracycline was reduced (one fold and more) yet the isolates stayed resistant.

It can be concluded that resistance to tetracycline in *S. sonnei* may be related to expression of *tetA*, but in these isolates other tetracycline-resistant factors are involved in resistance. On the other hand, two *S. sonnei*and two *S. flexneri* were positive for *tetA,* according to conventional PCR, while expression of *tetA* was negative by real time PCR. Also, in the presence of CCCP, MIC value of both isolates had no change. It can be concluded that high resistance of these two isolates is due to other factors other than the efflux pump.

Six tetracycline resistant isolates (*S. flexneri*), positive for *tetB* (according to conventional PCR and real time PCR), were changed to become susceptible by adding CCCP. It can be concluded that resistance to tetracycline in *S. flexneri* may be related to expression of *tetB*.

Ten isolates (*S. sonnei*) were negative for *tetA* by conventional PCR, but they were expressed using real time PCR. Comparison of conventional PCR and real time PCR results showed that the detection of genes by real time PCR is more reliable ([Table 4](#T4){ref-type="table"}).

Conclusion
==========

The mechanism of resistances to antibiotics can be different among species of a genus of bacteria. Increased resistance to antibiotics is one of the most important challenges around world, hence in order to prevent the emergence of resistant strains and to choose an appropriate treatment, the susceptibility test for each isolate should be more carefully monitored.

High resistance to tetracycline in *Shigella* isolates means that it cannot be a suitable choice for treatment of shigellosis but using suitable efflux pump inhibitors may change this result.

Resistance to tetracycline in *S.sonnei* and *S. flexneri* may be related to *tetA* and tetB genes, respectively.
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